Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

274
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
274
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

140
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
140
Seizures: Classification01:13

Seizures: Classification

582
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
582
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

272
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
272
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

505
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
505
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

438
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
438

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study protocol for a prospective, cluster randomised control, hybrid type 1 effectiveness-implementation trial to evaluate the Reduction Of Seizures through Education and Support: the ROSES study.

BMJ neurology open·2026
Same author

Reviewer Comment on Injar et al. "Screening and management of depression and anxiety in people with epilepsy: A quality improvement study".

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Annual Course / From Then to Now: The Evolving Spectrum of Epilepsy Care.

Epilepsy currents·2025
Same author

Interictal Psychosis-A New Reason to Conduct Epilepsy Gene Testing?

Epilepsy currents·2025
Same author

Randomized Controlled Trial of Acoustic Neuromodulation to Enhance Well-Being in Healthcare Workers.

Global advances in integrative medicine and health·2025
Same author

Implementing electronic health record-based anxiety and depression screening in an epilepsy clinic: Theory-based implementation strategy and pre-post quantitative outcomes using Reach, Effectiveness, Adoption, Implementation, and Maintenance.

Journal of clinical and translational science·2025

Related Experiment Video

Updated: Sep 7, 2025

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.9K

Suicide and Epilepsy.

Luciana Giambarberi1,2, Heidi M Munger Clary3

  • 1Department of Psychiatry, Wake Forest University School of Medicine, Winston-Salem, NC, USA. Lgiambar@wakehealth.edu.

Current Neurology and Neuroscience Reports
|June 17, 2022
PubMed
Summary
This summary is machine-generated.

People with epilepsy face a higher risk of suicide. Identifying risk factors like younger age, poor support, and specific epilepsy types is crucial for effective management and closing care gaps.

Keywords:
Antiseizure medicationDepressionEpilepsyScreeningSuicide

More Related Videos

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
10:25

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits

Published on: March 27, 2021

6.1K
Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

400

Related Experiment Videos

Last Updated: Sep 7, 2025

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.9K
Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
10:25

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits

Published on: March 27, 2021

6.1K
Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

400

Area of Science:

  • Neurology
  • Psychiatry
  • Public Health

Background:

  • Epilepsy (PWE) exhibits a significant bidirectional link with suicidality.
  • Patients with epilepsy have a substantially elevated risk of suicide compared to the general population.

Purpose of the Study:

  • To review current literature on suicide risk factors, assessment, and management in people with epilepsy.
  • To highlight unique considerations for this patient population.

Main Methods:

  • Literature review of recent studies on suicidality in epilepsy.
  • Analysis of identified risk factors, assessment strategies, and management approaches.

Main Results:

  • Key risk factors include younger age, psychiatric comorbidities (depression, anxiety, OCD, alcohol use), poor social support, and epilepsy characteristics (frequent seizures, temporal lobe epilepsy, drug-resistant epilepsy).
  • While clinicians recognize the need to address suicidality, approaches vary, indicating care gaps.
  • Screening strategies are proposed to mitigate these gaps.

Conclusions:

  • Understanding specific risk factors is vital for managing suicidality in people with epilepsy.
  • Standardized screening and management protocols are needed to improve care for this vulnerable population.